» Blog Archive » Pioglitazone Improves Metabolic Markers in Patients with Type 2 Diabetes Independently from Physical Activities: Results from the IRIS III Study
Thomas Schöndorf, Andreas Pfützner, Georg Lübben, Efstrathios Karagiannis, Werner Roth, and Thomas ForstJournal of Diabetes Science and Technology, March 2008, Volume 2, Issue 2: Page 244-249Abstract / Full Text (PDF)
Comments are closed.
Designed By C.R.S. Inc. Copyright(c)2006-2010 Diabetes Technology Society